
Abstract Background Monitoring pathogens of bloodstream infections (BSI) and their antibiotic susceptibility is important to guide empiric antibiotic treatment strategies and prevention programs. This study assessed the epidemiology of BSI and antibiotic resistance patterns at the German Federal State of Thuringia longitudinally. Methods A surveillance network consisting of 26 hospitals was established to monitor BSIs from 01/2015 to 12/2019. All blood culture results, without restriction of age of patients, of the participating hospitals were reported by the respective microbiological laboratory. A single detection of obligate pathogens and a repeated detection of coagulase-negative staphylococci, Bacillus spp., Corynebacterium spp., Micrococcus spp. and Propionibacterium spp., within 96 h were regarded as a relevant positive blood culture. If one of the aforementioned non-obligate pathogens has been detected only once within 96 h, contamination has been assumed. Logistic regression models were applied to analyse the relationship between resistance, year of BSI and hospital size. Generalized estimating equations were used to address potential clustering. Results A total of 343,284 blood cultures (BC) of 82,527 patients were recorded. Overall, 2.8% (n = 9571) of all BCs were classified as contaminated. At least one relevant pathogen was identified in 13.2% (n = 45,346) of BCs. Escherichia coli (25.4%) was the most commonly detected pathogen, followed by Staphylococcus aureus (15.2%), Staphylococcus epidermidis (8.1%) and Klebsiella pneumoniae (4.6%). In S. aureus, we observed a decline of methicillin resistance (MRSA) from 10.4% in 2015 to 2.5% in 2019 (p < 0.001). The rate of vancomycin resistance in Enterococcus faecium (VRE) has increased from 16.7% in 2015 to 26.9% in 2019 (p < 0.001), with a peak in 2018 (42.5%). In addition, we observed an increase of Cefotaxime (3GC) resistance in E. coli from 10.7% in 2015 to 14.5% in 2019 (p = 0.007) whereas 3GC resistance in K. pneumoniae was stable (2015: 9.9%; 2019: 7.4%, p = 0.35). Carbapenem resistance was less than 1% for both pathogens. These patterns were robustly observed across sensitivity analyses. Conclusions We observed evidence for a decline in MRSA, an increase in VRE and a very low rate of carbapenem resistance in gram-negative bacteria. 3GC resistance in E. coli increased constantly over time.
Methicillin-Resistant Staphylococcus aureus, Epidemiology, Enterococcus faecium, MRSA, Infectious and parasitic diseases, RC109-216, Germany, Sepsis, Escherichia coli, Staphylococcus epidermidis, Humans, Prospective Studies, Aged, Candida, Aged, 80 and over, Surveillance, Research, Drug Resistance, Microbial, Vancomycin Resistance, Middle Aged, Sepsis/microbiology [MeSH] ; Aged, 80 and over [MeSH] ; Aged [MeSH] ; Surveillance ; MRSA ; Vancomycin Resistance [MeSH] ; Germany/epidemiology [MeSH] ; Epidemiology ; Sepsis/epidemiology [MeSH] ; Klebsiella pneumoniae/drug effects [MeSH] ; Methicillin-Resistant Staphylococcus aureus/physiology [MeSH] ; Methicillin Resistance [MeSH] ; Escherichia coli/drug effects [MeSH] ; Humans [MeSH] ; Prospective Studies [MeSH] ; Candida/drug effects [MeSH] ; Middle Aged [MeSH] ; Bloodstream infections ; Carbapenems/pharmacology [MeSH] ; Sepsis/drug therapy [MeSH] ; Research ; Drug Resistance, Microbial [MeSH] ; Staphylococcus epidermidis/drug effects [MeSH] ; Enterococcus faecium/drug effects [MeSH] ; ESBL, Klebsiella pneumoniae, ESBL, Carbapenems, Methicillin Resistance, Bloodstream infections
Methicillin-Resistant Staphylococcus aureus, Epidemiology, Enterococcus faecium, MRSA, Infectious and parasitic diseases, RC109-216, Germany, Sepsis, Escherichia coli, Staphylococcus epidermidis, Humans, Prospective Studies, Aged, Candida, Aged, 80 and over, Surveillance, Research, Drug Resistance, Microbial, Vancomycin Resistance, Middle Aged, Sepsis/microbiology [MeSH] ; Aged, 80 and over [MeSH] ; Aged [MeSH] ; Surveillance ; MRSA ; Vancomycin Resistance [MeSH] ; Germany/epidemiology [MeSH] ; Epidemiology ; Sepsis/epidemiology [MeSH] ; Klebsiella pneumoniae/drug effects [MeSH] ; Methicillin-Resistant Staphylococcus aureus/physiology [MeSH] ; Methicillin Resistance [MeSH] ; Escherichia coli/drug effects [MeSH] ; Humans [MeSH] ; Prospective Studies [MeSH] ; Candida/drug effects [MeSH] ; Middle Aged [MeSH] ; Bloodstream infections ; Carbapenems/pharmacology [MeSH] ; Sepsis/drug therapy [MeSH] ; Research ; Drug Resistance, Microbial [MeSH] ; Staphylococcus epidermidis/drug effects [MeSH] ; Enterococcus faecium/drug effects [MeSH] ; ESBL, Klebsiella pneumoniae, ESBL, Carbapenems, Methicillin Resistance, Bloodstream infections
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 33 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
